Product
Supplier
Encyclopedia
Inquiry
Home > News > Market Flash > Lupin's Pithampur Unit Gets Health Canada Clearance

Lupin's Pithampur Unit Gets Health Canada Clearance

Chemical Weekly 2018-04-12

Lupin has said that its Pithampur unit 2 manufacturing facility located in Indore has been cleared by Health Canada after a review. “Following the review, Health Canada has maintained the compliant rating for unit 2 at Pithampur (Indore) and has issued a revised ‘Establishment License’,” Lupin said in a stock market filing.

In November 2017, Lupin had received warning letter from US Food and Drug Administration (FDA) for its manufacturing facilities in Goa and Pithampur, Indore.

 

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.